CASP Module 25: Introduction to Future of Specialty Pharmacy & Global Perspectives
CASP Certification Program

Module 25: Future of Specialty Pharmacy & Global Perspectives

Navigating the Evolving Landscape of High-Cost Care Worldwide.

Charting the Course: Global Trends & Future Frontiers in Specialty Care

Throughout this program, we have undertaken a deep dive into the complexities of specialty pharmacy practice within the current U.S. health system. You have mastered advanced therapeutics, intricate access navigation, and the critical human dimensions of patient care. You are equipped to excel as a leader in today’s high-touch, high-cost medication environment.

However, the landscape of specialty pharmacy is anything but static. It is a dynamic field shaped by rapid scientific innovation, evolving market forces, technological disruption, and shifting policy priorities—not just domestically, but globally. To maintain your position at the forefront of the profession, you must move beyond mastering the present and actively anticipate the future.

This module shifts our perspective outward and forward. We will explore how different countries structure and finance specialty care, providing valuable insights into alternative models and potential future directions for the U.S. We will analyze the seismic shifts being driven by biosimilars, digital therapeutics, and decentralized clinical trials, and consider their profound implications for HSSP practice. Finally, we will contemplate the evolving role of the specialty pharmacist—not just as a clinician, but as an innovator, a data scientist, and a crucial voice in shaping the policies that will define the future of equitable access to transformative therapies worldwide.

Your Guide to the Global & Future Landscape

This module will equip you with the foresight and global context needed to lead and innovate in the next era of specialty pharmacy.

25.1 Global Specialty Market Structures

A comparative analysis of how different countries (e.g., UK, Germany, Canada, Japan) approach the pricing, reimbursement, distribution, and clinical management of high-cost specialty medications, highlighting key differences and similarities to the US model.

25.2 Biosimilar and Biologic Market Evolution

Examining the impact of biosimilar introductions on market dynamics, pricing pressures, interchangeability challenges, provider and patient acceptance, and the evolving role of the HSSP in managing biologic/biosimilar formulary strategies and education.

25.3 Decentralized Trials and Digital Therapeutics

Exploring the rise of remote clinical trial models and FDA-approved digital therapeutics (DTx) in specialty care, focusing on the HSSP’s role in patient recruitment, remote monitoring, data integration, and managing the unique access/reimbursement pathways for DTx.

25.4 Global Data Exchange and Cross-Border Compliance

Analyzing the challenges and opportunities in sharing specialty pharmacy data across international borders for research, pharmacovigilance, and care coordination, including navigating complex privacy regulations (e.g., GDPR) and data standardization efforts.

25.5 The Pharmacist as Innovator and Policy Shaper

A forward-looking perspective on how HSSPs can leverage their unique clinical, access, and data expertise to drive innovation within their health systems (e.g., developing new care models, utilizing predictive analytics) and shape broader health policy to ensure sustainable, equitable access to future specialty therapies.